Composition: Paracetamol 325mg + Phenylephrine 5mg + Guaiphenesin 50mg + Cetirizine HCl 5mg + Ambroxol HCl 15mg (tablets). It combines Paracetamol (analgesic and antipyretic), Phenylephrine (nasal decongestant), Guaiphenesin (expectorant), Cetirizine (second-generation antihistamine) and Ambroxol (mucolytic); each component acts on a different part of the clinical problem.
Paracetamol is an analgesic and antipyretic. Phenylephrine is an alpha-adrenergic agonist that relieves nasal congestion through vasoconstriction. Guaiphenesin is an expectorant that helps loosen bronchial secretions. Cetirizine is a second-generation H1-antihistamine. Ambroxol is a mucolytic that thins mucus and promotes its clearance.
NILLE-COLD is a prescription medicine from Aerochem Neutron's respiratory range, for use on the prescription of a registered medical practitioner.
· Contains Paracetamol 325mg + Phenylephrine 5mg + Guaiphenesin 50mg + Cetirizine HCl 5mg + Ambroxol HCl 15mg
· Paracetamol — analgesic and antipyretic
· Phenylephrine — alpha-adrenergic agonist that relieves nasal congestion through vasoconstriction
· Guaiphenesin — expectorant that helps loosen bronchial secretions
· Cetirizine — second-generation H1-antihistamine
· Ambroxol — mucolytic that thins mucus and promotes its clearance
Presented as tablets· Common cold and flu with productive cough
· Nasal congestion, sneezing and runny nose
· Fever and body ache associated with cold
· Note: indications reflect established uses of the individual molecules; confirm against the CDSCO-approved label for this fixed-dose combination
Safety
· Contraindicated in patients with known hypersensitivity to any component.
· Risk of hepatotoxicity with overdose or with other paracetamol-containing products; use caution in liver disease and chronic alcohol use.
· Sympathomimetic decongestants should be used with caution in hypertension, heart disease, hyperthyroidism, diabetes and prostatic enlargement, and are contraindicated with MAO inhibitors.
· May cause drowsiness; caution in renal impairment.
· Rare severe cutaneous reactions have been reported; discontinue if rash develops.
· Pregnancy and lactation: use only if the prescriber judges the benefit to outweigh the risk.
Clinical Rationale: The mechanisms and labelled uses of acetaminophen, phenylephrine, guaifenesin, cetirizine, ambroxol described here follow the US prescribing information (DailyMed). Use of the combination should follow the CDSCO-approved label for this fixed-dose combination.
References (Verified)
· DailyMed (US NLM) prescribing information – acetaminophen: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ACETAMINOPHEN
· DailyMed (US NLM) prescribing information – phenylephrine: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=PHENYLEPHRINE
· DailyMed (US NLM) prescribing information – guaifenesin: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=GUAIFENESIN
· DailyMed (US NLM) prescribing information – cetirizine: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=CETIRIZINE
· DailyMed (US NLM) prescribing information – ambroxol: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=AMBROXOL
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about NILLE COLD for professional use.